Other Income & Expense
Derivative Gain (Loss) Excluded from Effectiveness
Howmet Aerospace Derivative Gain (Loss) Excluded from Effectiveness decreased by 16.2% to -$43.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.3%, from -$39.00M to -$43.00M. Over 2 years (FY 2022 to FY 2025), Derivative Gain (Loss) Excluded from Effectiveness shows an upward trend with a -18.8% CAGR.
Analysis
StatementIncome Statement
SectionOther Income & Expense
First reportedQ1 2022
Last reportedQ1 2026May 7, 2026
Metric ID:
abbv_derivative_gain_loss_excluded_from_effectivenessHistorical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$57.25M | -$57.25M | -$57.25M | -$57.25M | -$54.00M | -$52.00M | -$49.00M | -$49.00M | -$44.00M | -$40.00M | -$39.00M | -$38.00M | -$37.00M | -$37.00M | -$43.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +5.7% | +3.7% | +5.8% | +0.0% | +10.2% | +9.1% | +2.5% | +2.6% | +2.6% | +0.0% | -16.2% |
| YoY Change | — | — | — | — | +5.7% | +9.2% | — | — | +18.5% | +23.1% | +20.4% | +22.4% | +15.9% | +7.5% | -10.3% |
Range-$57.25M – -$37.00M
CAGR-7.9%
Avg YoY Growth+12.5%
Median YoY Growth+15.9%
Derivative Gain (Loss) Excluded from Effectiveness at Other Companies
Frequently Asked Questions
- What is Howmet Aerospace's derivative gain (loss) excluded from effectiveness?
- Howmet Aerospace (HWM) reported derivative gain (loss) excluded from effectiveness of -$43.00M in Q1 2026.
- How has Howmet Aerospace's derivative gain (loss) excluded from effectiveness changed year-over-year?
- Howmet Aerospace's derivative gain (loss) excluded from effectiveness decreased by 10.3% year-over-year, from -$39.00M to -$43.00M.
- What is the long-term trend for Howmet Aerospace's derivative gain (loss) excluded from effectiveness?
- Over 2 years (2022 to 2025), Howmet Aerospace's derivative gain (loss) excluded from effectiveness has grown at a -18.8% compound annual growth rate (CAGR), from -$229.00M to -$151.00M.